DRMA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DRMA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Dermata Therapeutics has the Momentum Rank of 0.
For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.
Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.
For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Thank you for viewing the detailed overview of Dermata Therapeutics's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Brittany Bradrick | director | C/O DERMATA THERAPEUTICS, INC., 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO CA 92130 |
Gerald T Proehl | 10 percent owner, officer: Pres., CEO and Chairman | |
Van Hoose Kyri K. | officer: Chief Financial Officer | C/O TURNING POINT THERAPEUTICS, INC., 10628 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO CA 92121 |
Mary Fisher | director | C/O ACORDA THERAPEUTICS, INC., 15 SKYLINE DRIVE, HAWTHORNE NY 10532 |
David F Hale | director | 1042-B NORTH EL CAMINO REAL, SUITE 430, ENCINITAS CA 92024 |
Steven J Mento | director | C/O SANGAMO BIOSCIENCES, INC., 501 CANAL BLVD SUITE A-100, RICHMOND CA 94804 |
Wendell Wierenga | director | C/O CIPHERGEN BIOSYSTEMS INC, 6611 DUMBARTON CIRCLE, FREMONT CA 94555 |
Kathleen D. Scott | director | C/O CONATUS PHARMACEUTICALS INC., 16745 WEST BERNARDO DRIVE, SUITE 200, SAN DIEGO CA 92127 |
Thomas Insley | officer: Chief Financial Officer | SKINMEDICA, INC., 5909 SEA LION PLACE, SUITE H, CARLSBAD CA 92010 |
Bedoya-toro Munera Maria E | officer: Senior VP | 10590 WEST OCEAN AIR DRIVE, SUITE 200, SAN DIEGO CA 92130 |
Andrew Seth Sandler | director | 1301 2ND AVE, SEATTLE WA 98101 |
Christopher J. Nardo | officer: Senior VP, Development | C/O DERMATA THERAPEUTICS, INC., 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO CA 92130 |
Proehl Investment Ventures Llc | 10 percent owner | C/O DERMATA THERAPEUTICS, INC., 3525 DEL MAR HEIGHTS RD., #332, SAN DIEGO CA 92130 |
From GuruFocus
By ACCESSWIRE ACCESSWIRE • 08-25-2022
By ACCESSWIRE ACCESSWIRE • 05-23-2022
By ACCESSWIRE ACCESSWIRE • 08-16-2022
By ACCESSWIRE ACCESSWIRE • 11-11-2022
By ACCESSWIRE • 11-16-2023
By ACCESSWIRE • 08-31-2023
By ACCESSWIRE ACCESSWIRE • 03-24-2022
By ACCESSWIRE • 06-27-2023
By ACCESSWIRE ACCESSWIRE • 01-13-2022
By ACCESSWIRE ACCESSWIRE • 06-08-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.